SPDR Pharma ETF (XPH-N) Stock Predictions - Stockchase
WATCH LIST
7
SPDR Pharma ETF (XPH-N)

ON STOCKCHASE SINCE Aug 2013

E.T.F.'s

SPDR Pharma ETF

XPH-N

1 watching          
Join the Discussion

SPDR Pharma ETF (XPH-N) SAVE Apr, 25, 2019, 4:05 am

39.42 0.18 (0.45%)

What the experts are saying about XPH-N



  • All
  • Filtered
Signal Opinion Expert
BUY on WEAKNESS
SPDR Pharma ETF(XPH-N) 

August 31, 2018

This is in an incredibly strong trend, so be careful of the entry point.  Healthcare might give a little more opportunity like the IYH-N ETF or an equal weight XLV-N ETF.  

E.T.F.'s
0 0 0 0 0
0 comments

This is in an incredibly strong trend, so be careful of the entry point.  Healthcare might give a little more opportunity like the IYH-N ETF or an equal weight XLV-N ETF.  

E.T.F.'s
0 0 0 0 0
0 comments
Mike Philbrick

President, ReSolve Asset Manage...

Price Price
$49.960
Owned Owned
No

BUY
SPDR Pharma ETF(XPH-N) 

December 12, 2016

We have a base.  It was beat up by Hillary Clinton.  The sector is in a secular bull market, however.  This is a good place to get your initial allocation.  We come into a seasonal period soon.  There is decent value.

E.T.F.'s
0 0 0 0 0
0 comments

We have a base.  It was beat up by Hillary Clinton.  The sector is in a secular bull market, however.  This is a good place to get your initial allocation.  We come into a seasonal period soon.  There is decent value.

E.T.F.'s
0 0 0 0 0
0 comments
Hap (Robert) Sn

Chief Port, Castlemoore Inc....

Price Price
$40.680
Owned Owned
Unknown

PAST TOP PICK
SPDR Pharma ETF(XPH-N) 

November 25, 2016

(A Top Pick Aug 10/16. Down 12.87%.) This has been frustrating with controversies and the possibility of a Clinton presidency. Now all of that has come off, and this has gapped higher from a depressed level. It is now testing that gap support at around $39. If it can hold that, there might actually be a play here. If you own this, continue to hold as there might be some good things happening.

E.T.F.'s
0 0 0 0 0
0 comments

(A Top Pick Aug 10/16. Down 12.87%.) This has been frustrating with controversies and the possibility of a Clinton presidency. Now all of that has come off, and this has gapped higher from a depressed level. It is now testing that gap support at around $39. If it can hold that, there might actually be a play here. If you own this, continue to hold as there might be some good things happening.

E.T.F.'s
0 0 0 0 0
0 comments
Jon Vialoux

Research A, CastleMoore Inc....

Price Price
$40.680
Owned Owned
No

TOP PICK
SPDR Pharma ETF(XPH-N) 

August 10, 2016

Pharmaceutical stocks tend to do well between August and November. Between August 13 and November 21, it tends to gain an average of 5.5%, and has been positive 80% of the time over the past 20 years. This is the period were shipments of pharmaceuticals and medicines tend to increase for the start of the cold and flu season. The 3rd quarter tends to be the best quarter for some of these Pharma stocks. This ETF owns a wide variety of pharmaceutical stocks and not all of them are high yielding, but you tend to benefit from the seasonal strength. Dividend yield of about 0.5%.

E.T.F.'s
0 0 0 0 0
0 comments

Pharmaceutical stocks tend to do well between August and November. Between August 13 and November 21, it tends to gain an average of 5.5%, and has been positive 80% of the time over the past 20 years. This is the period were shipments of pharmaceuticals and medicines tend to increase for the start of the cold and flu season. The 3rd quarter tends to be the best quarter for some of these Pharma stocks. This ETF owns a wide variety of pharmaceutical stocks and not all of them are high yielding, but you tend to benefit from the seasonal strength. Dividend yield of about 0.5%.

E.T.F.'s
0 0 0 0 0
0 comments
Jon Vialoux

Research A, CastleMoore Inc....

Price Price
$46.750
Owned Owned
No

COMMENT
SPDR Pharma ETF(XPH-N) 

June 30, 2016

Which stocks for RESP and University in 8 years? He would use healthcares such as SPDR Health Care (XLV-N) or SPDR Pharma (XPH-N). These are in a secular bull market. You could also use Van Eck Vectors Biotech (BBH-Q). This gives you a little bit of mix of all 3 sectors. He would suggest 40% and 40% on the first 2 and maybe 20% in the Biotechs.

E.T.F.'s
0 0 0 0 0
0 comments

Which stocks for RESP and University in 8 years? He would use healthcares such as SPDR Health Care (XLV-N) or SPDR Pharma (XPH-N). These are in a secular bull market. You could also use Van Eck Vectors Biotech (BBH-Q). This gives you a little bit of mix of all 3 sectors. He would suggest 40% and 40% on the first 2 and maybe 20% in the Biotechs.

E.T.F.'s
0 0 0 0 0
0 comments
Hap (Robert) Sn

Chief Port, Castlemoore Inc....

Price Price
$41.795
Owned Owned
Unknown

PAST TOP PICK
SPDR Pharma ETF(XPH-N) 

November 18, 2013

(A Top Pick Aug 22/13. Up 14.37%.) Probably the only play that has seasonal strength through to the end of the year. Pharmaceutical stocks tend to peak right around now.

E.T.F.'s
0 0 0 0 0
0 comments

(A Top Pick Aug 22/13. Up 14.37%.) Probably the only play that has seasonal strength through to the end of the year. Pharmaceutical stocks tend to peak right around now.

E.T.F.'s
0 0 0 0 0
0 comments
Jon Vialoux

Research A, CastleMoore Inc....

Price Price
$86.260
Owned Owned
No

TOP PICK
SPDR Pharma ETF(XPH-N) 

August 22, 2013

Pharmaceuticals tend to do well from right about now through to the end of the year. He had read where Obama care would be injecting $10 billion-$35 billion in additional profits into the pharmaceutical industry over the next 10 years.

E.T.F.'s
0 0 0 0 0
0 comments

Pharmaceuticals tend to do well from right about now through to the end of the year. He had read where Obama care would be injecting $10 billion-$35 billion in additional profits into the pharmaceutical industry over the next 10 years.

E.T.F.'s
0 0 0 0 0
0 comments
Jon Vialoux

Research A, CastleMoore Inc....

Price Price
$75.440
Owned Owned
No

Showing 1 to 7 of 7 entries
Successfully Saved Company
Successfully Saved Company
1+
JOIN THE DISCUSSION
1 comments in the last 7 days